smooth muscle actin specific Polyclonal antibody
smooth muscle actin specific Polyclonal Antibody for IF, IHC, WB, ELISA
Cat no : 55135-1-AP
Validation Data Gallery
|Positive WB detected in
|mouse colon tissue, mouse kidney tissue, mouse stomach, rat colon, mouse lung, rat lung
|Positive IHC detected in
|human heart tissue, human liver cancer tissue, human hepatocirrhosis tissue, human colon tissue, human colon cancer tissue, rat colon tissue, mouse colon tissue, mouse liver tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in
|mouse heart tissue
|Western Blot (WB)
|WB : 1:500-1:4000
|IHC : 1:20-1:200
|IF : 1:50-1:500
|It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
|Sample-dependent, check data in validation data gallery
55135-1-AP targets smooth muscle actin specific in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse, rat samples.
|human, mouse, rat
|human, mouse, rat, rabbit
|Host / Isotype
|Rabbit / IgG
|actin, alpha 2, smooth muscle, aorta
|Calculated molecular weight
|Observed molecular weight
|GenBank accession number
|Gene ID (NCBI)
|Antigen affinity purification
|PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
|Store at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.
ACTA2, also named as a-SMA,AAT6;ACTSA belongs to the actin family. Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. Defects in ACTA2 are the cause of aortic aneurysm familial thoracic type 6 (AAT6). The immunogen of this antibody is a specific domain of ACTA2. This antibody stains the aorta only.
|Product Specific Protocols
|WB protocol for smooth muscle actin specific antibody 55135-1-AP
|IHC protocol for smooth muscle actin specific antibody 55135-1-AP
|IF protocol for smooth muscle actin specific antibody 55135-1-AP
|Click here to view our Standard Protocols
Cysteine-Based Redox-Responsive Nanoparticles for Fibroblast-Targeted Drug Delivery in the Treatment of Myocardial Infarction
Cancer Commun (Lond)
Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer
Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis.
Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts.
Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy
HIF-1α promotes the migration and invasion of cancer-associated fibroblasts by miR-210
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
PK (Verified Customer) (03-22-2022)
S (Verified Customer) (12-01-2021)